Meizothrombin, an intermediate of prothrombin activation, stimulates human glioblastoma cells by interaction with PAR-1-type thrombin receptors

Journal of Neuroscience Research

Volumn 59, Issue 5, 2000, Pages 643-648

  Kaufmann, Roland ^a   Zieger, Michael ^a   Tausch, Svetlana ^a   Henklein, Peter ^b   Nowak, Götz ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Calcium; Meizothrombin; PAR 1; SNB 19 cells

Indexed keywords

CALCIUM; MEIZOTHROMBIN; PROTEINASE ACTIVATED RECEPTOR 1; PROTHROMBIN; THROMBIN; THROMBIN RECEPTOR;

ARTICLE; CALCIUM MOBILIZATION; CATALYSIS; CELL STIMULATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

CALCIUM; ENZYME PRECURSORS; GLIOBLASTOMA; HUMANS; INTRACELLULAR MEMBRANES; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PROTHROMBIN; RECEPTOR, PAR-1; RECEPTORS, THROMBIN; THROMBIN; TUMOR CELLS, CULTURED;

EID: 0034090334     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(20000301)59:5<643::AID-JNR7>3.0.CO;2-G     Document Type: Article

References (45)

1. Bar-Shavit R, Mudd M, Wilner G, Mann K, Fenton JW II. 1983. Monocyte chemotaxis: stimulation by specific exosite region in thrombin. Science 220:728-731.
2. Beecher KL, Andersen TT, Fenton JW II. 1994. Thrombin receptor peptides induce shape change in neonatal murine astrocytes in culture. J Neurosci Res 37:108-115.
3. Berliner LJ. 1984. Structure-function relationship in human alpha- and gamma-thrombin. Mol Cell Biochem 61:159-172.
4. Berndt M, Philipps D. 1981. Platelet membrane proteins: composition and receptor function. In: Gordon J, editor. Platelets in biology and pathology. Amsterdam: Elsevier/North Holland 198:43-47.
5. Blackhart BD, Cuenco G, Toda T, Scaborough RM, Wolf DL, Ramakrishnan V. 1994. The anion-binding exosite is critical for the high affinity binding of the thrombin receptor. Growth Factors 11:17-28.
6. Cavanaugh KP, Gurwitz D, Cunningham DD, Bradshaw RA. 1990. Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1. J Neurochem 54:1735-1743.
7. Collins LR, Ricketts WA, Olefsky JM, Brown JH. 1997. The G12 coupled thrombin receptor stimulates mitogenesis through the SH2 domain. Oncogene 15:595-600.
8. Coté HCF, Stevens WK, Bajzar L, Banfield DK, Nesheim ME, MacGillivray RTM. 1994. Characterization of a stable form of human meizothrombin derived from recombinant prothrombin (R 155A, R271A, R284A). J Biol Chem 269:11374-11380.
9. Deschepper CF, Bigornia V, Berens ME, Lapointe MC. 1991. Production of thrombin and antithrombin III by brain and astroglial cells. Mol Brain Res 11:355-358.
10. Dihanich M, Kaser M, Reinhard E, Cunningham D, Monard D. 1991. Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6:575-581.
11. Fenton JW. 1981. Thrombin specificity. Ann N Y Acad Sci 370:468-495.
12. Festoff BW, Smirnova IV, Ma JX, Citron BA. 1996. Thrombin, its receptor and protease nexin 1, its potent serpin, in the nervous system. Semin Thromb Hemost 22:267-271.
13. Fischer BE, Schlokat U, Himmelspach M, Dorner F. 1998. Binding of hirudin to meizothrombin. Protein Eng 11:715-721.
14. Glenn K, Carney D, Fenton J, Cunningham D. 1980. Thrombin active-site regions required for fibroblast receptor binding and initiation of cell division. J Biol Chem 255:6609-6616.
15. Gross JL, Behrens DL, Mullins DE, Korublith PL, Dexter DL. 1988. Plasminogen activator and inhibitor activity in human glioblastoma cells and modulation by sodium pyruvate. Cancer Res 48:291-296.
16. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
17. Gurwitz D, Cunningham D. 1988. Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc Natl Acad Sci USA 85:3440-3444.
18. Hemker HC. 1993. Thrombin generation, an essential step in haemostasis and thrombosis. In: Bloom AL, Forbes CD, Thomas DP, Tuddenhani EGD, editors. Haemostasis and thrombosis. Edinburgh: Churchill Livingstone. p. 477-490.
19. Ho GJ, Smirnova IV, Akaaboune M, Hantai D, Festoff BW. 1994. Serine proteases and their serpin inhibitors in Alzheimer's disease. Biomed Pharmacother 48:296-304.
20. Ishihara H, Conolly AW, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T, Coughlin SR. 1997. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386:502-506.
21. Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng DW, Moff S, Farese RV, Tam C, Couhlin SR. 1998. A dual thrombin receptor system for platelet activation. Nature 349:690-694.
22. Kahn ML, Nakanishi-Matsui, Shapiro MJ, Ishihara I, Coughlin SH. 1999. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 103:879-887.
23. 6 cells. J Neurosci Res 46:641-651.
24. Kaufmann R, Patt S, Schafberg H, Kalff R, Neupert G, Nowak G. 1998a. Functional thrombin receptor PAR1 in primary cultures of human glioblastoma cells. NeuroReport 9:709-712.
25. Kaufmann R, Hoffmann J, Ramakrishnan V, Nowak G.1998b. Intermediates of prothrombin activation induce intracellular calcium mobilization in rat aortic smooth muscle cells. Thromb Haemost 80:1018-1021.
26. Kaufmann R, Patt S, Kraft R, Zieger M, Henklein P, Neupert G, Nowak G. 1999. PAR 1-type thrombin receptors are involved in thrombin-induced calcium signaling in human meningioma cells. J Neuro-Oncol 42:131-136.
27. Krishnaswamy S, Mann KG, Nesheim ME. 1986. The prothrombinase-catalyzed activation of prothrombin proceeds through the intermediate meizothrombin in an ordered, sequential reaction. J Biol Chem 261: 8977-8984.
28. Majumdar M, Seasholtz TM, Goldstein D, de Lanerolle P, Brown JH. 1998. Requirement for rho-mediated myosin light chain phosphorylation in thrombm-stimulated cell rounding and its dissociation from mitogenesis. J Biol Chem 237:10099-10106.
29. Nanevicz T, Ishii M, Wang L, Chen M, Chen J, Turck CW, Cohen F, Coughlin SR. 1995. Mechanism of thrombin receptor agonist specifity. Chimeric receptors and complementary mutations identify an agonist recognition site. J Biol Chem 270:21619-21625.
30. Nierodzik ML, Kajumo LR, Karpatkin S. 1992. Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Cancer Res 52:3267-3272.
31. Nystedt S, Emilsson K, Wahlstedt C, Sundelin J. 1994. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 91:9208-9212.
32. Rosing J, Tans G. 1988. Meizothrombin, a major product of factor Xa-catalyzed prothrombin activation. Thromb Haemost 60:335-360.
33. Rosing J, Zwaal RFA, Tans G. 1986. Formation of meizothrombin as an intermediate in factor Xa-catalyzed prothrombin activation. J Biol Chem 261:4224-4228.
34. Rydel TJ, Ravichandran KG, Tulinsky A, Bode W, Huber R, Roitch C, Fenton II JW. 1990. The structure of a complex of recombinant hirudin and human α-thrombin. Science 249:277-280.
35. Scase TJ. Heath MF. Evans RJ. 1997. Cloning of PAR3 from human platelets, and human erythroleukemic and human promonocytic cell lines. Blood 90:2113-2114.
36. Smirnova IV, Ho GJ, Fenton JWI, Festoff BW. 1994. Extravascular protcolysis and the nervous system: serine protease/serpin balance. Semin Thromb Hemost 20:426-432.
37. Suidan HS, Stone SR, Hemmings BA, Monard D. 1992. Thrombin causes neurite retraction in neuronal cells through activation of cell surface receptors. Neuron 8:363-375.
38. Suidan HS, Niclou SP, Monard D. 1996. The thrombin receptor in the nervous system. Semin Thromb Hemost 22:125-133.
39. Tans G, Janssen-Claessen T, Hemker HC, Zwall RFA, Rosing J. 1991. Meizothrombin formation during factor Xa-catalyzed prothrombin activation. Formation in a purified system and in plasma. J Biol Chem 266: 21864-21873.
40. Turner JS, Redpath GT, Humphries JE, Gonias SL, Vandenberg SR. 1994. Plasmin modulates die thrombin-evoked calcium response in C6 glioma cells. Biochem J 297:175-179.
41. 1-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells. Neuroscience 86:597-609.
42. Vu T-K, Hung DT, Wheaton VI, Coughlin SR. 1991. Molecular cloning of a functional thrombin receptor reveals a novel mechanism of receptor activation. Cell 64:1057-1068.
43. Weidt P, Möller T, Labrakakis C, Patt S, Kettenmann H. 1997. Neuroligand-triggered calcium signalling in cultured human glioma cells. Neurosci Lett 228:91-94.
44. Welch WC, Morrison RS, Gross JL, Gollin SM, Kitson RB, Goldfarb RH, Giuliano KA, Bradley MK, Kornblith PL. 1995. Morphologic, immunologic, biochemical, and cytogenetic characteristics of the human glioblastoma-derived cell line, SNB-19. In Vitro Cell Dev Biol-Animal 31:610-616.
45. Xu W-F, Andersen H, Whitmore TE, Presnell SR, Yee DP, Ching A, Gilbert T, Davie EA, Foster CA. 1998. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 95:6642-6664.